Paid Clinical Trials in Tacoma, WA
As of June 2026, 183 paid clinical trials are recruiting in Tacoma, Washington. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Tacoma offers studies at sites including Mary Bridge Children's Hospital and Health Center for conditions such as Breast Cancer, Multiple Myeloma, Crohn's Disease, Breast Neoplasms. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Tacoma
Trials by drug in Tacoma
Filter results
183 clinical trials
↓ Download CSVA Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
EMBRACE Study: Enduring Migraine Benefit From Responsive Artery Coil Embolization
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
The PROmoting Pain Self-Management (PROs) Trial: Holistic Pain Care in the Military Health System
A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
ELEVATE-HFpEF Clinical Study
Limited Versus Extended Trophic Feeding (LET-FEED) Trial
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
About research studies in Tacoma
Tacoma has approximately 183 recruiting research studies across a wide range of therapeutic areas. Washington hosts Fred Hutchinson Cancer Center, UW Medicine, and Seattle Children's — widely recognized for leadership in bone marrow transplantation, immunotherapy, and infectious disease research.
Top Research Study Locations in Tacoma
Researchers run research studies in Tacoma, WA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Mary Bridge Children's Hospital and Health Center | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Ganglioneuroblastoma, Nodular | 22 |
| Franciscan Research Center-Northwest Medical Plaza | Chronic Lymphocytic Leukemia, Malignant Solid Neoplasm, Melanoma | 20 |
| Madigan Army Medical Center | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Metastatic Osteosarcoma | 20 |
| Northwest Medical Specialties | Breast Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma | 17 |
| Northwest Medical Specialties PLLC | Breast Cancer, Stage IIIB Lung Cancer AJCC v8, Advanced Lung Non-Squamous Non-Small Cell Carcinoma | 15 |
| Northwest Medical Specialties, PLLC | Breast Cancer Metastatic, Ovarian Cancer, Advanced Cancer | 13 |
| MultiCare Tacoma General Hospital | Anatomic Stage IV Breast Cancer AJCC v8, Breast Cancer, Cardiotoxicity | 7 |
| MultiCare Institute for Research & Innovation | Crohn's Disease, Hypogonadism, Male, Metastatic Non-small Cell Lung Cancer | 7 |
| Northwest Medical Specialties Tacoma | Chronic Lymphocytic Leukemia, Multiple Myeloma, Non Small Cell Lung Carcinoma | 6 |
| Washington Gastroenterology - Tacoma | Obesity or Overweight, Crohn's Disease, Metabolic Dysfunction-Associated Steatotic Liver Disease | 4 |
| MultiCare Health System | Breast Neoplasms, Colitis, Ulcerative, Neoplasm Metastasis | 4 |
| Universal Research Group | Alzheimer Disease, Atherosclerotic Cardiovascular Disease (ASCVD), Dementia | 3 |
| MultiCare Institute for Research and Innovation | Percutaneous Coronary Intervention, Peripheral Endovascular Intervention, Migraine | 3 |
| Mary Bridge Children's Health | Sickle Cell Disease, Thalassemia | 2 |
| GI Alliance Tacoma | Colitis, Ulcerative, Crohn Disease | 2 |
| GSK Investigational Site | Gastrointestinal Neoplasms, Neoplasms, Head and Neck | 2 |
| Mary Bridge Children's Hospital & Health Center | Cerebroside Lipidosis Syndrome, Gaucher Disease, Glucocerebrosidase Deficiency Disease | 2 |
| Multicare Health System - Mary Bridge Pediatrics | Developmental and Epileptic Encephalopathy, Dravet Syndrome | 2 |
| Washington Gastroenterology- GIA | Crohn's Disease, Ulcerative Colitis | 2 |
| Northwest Medical Specialties - Tacoma | Patients With Non-Small Cell Lung Cancer, Follicular Lymphoma (FL) | 2 |
| 019 | Advanced Solid Tumor | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| CHI Franciscan Research Center | Heart Failure, Obesity | 1 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Clinical Trial Site | Acid Cholesteryl Ester Hydrolase Deficiency, Type 2, Acid Lipase Deficiency, Cholesterol Ester Storage Disease | 1 |
Active & Upcoming Studies in Tacoma (2026)
Recruiting trials in Tacoma grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (91 active studies)
Neurology & pain (12 active studies)
- A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy · Phase 4 · Genentech, Inc.
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). · Phase 3 · Eli Lilly and Company
Cardiovascular (12 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention · Phase 4 · Duke University
Diabetes & metabolic (7 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes · Phase 2 · SAb Biotherapeutics, Inc.
Mental health & behavior (1 active study)
- Lay-Delivered Behavioral Activation in Senior Centers · University of Washington
Pediatric (1 active study)
- A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine · Phase 3 · H. Lundbeck A/S
Common conditions studied in Tacoma
- Breast Cancer (8 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Multiple Myeloma (8 active studies). Recruiting Multiple Myeloma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Crohn's Disease (7 active studies). Recruiting Crohn's Disease studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Breast Neoplasms (5 active studies). Recruiting Breast Neoplasms studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Colitis, Ulcerative (5 active studies). Recruiting Colitis, Ulcerative studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Non-small Cell Lung Cancer (5 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
Leading research sponsors in Tacoma
- AstraZeneca
- National Cancer Institute (NCI)
- Children's Oncology Group
- AbbVie
- Eli Lilly and Company
Local regulations and guidelines
Clinical trials in Washington are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Studies in Washington must also comply with the My Health My Data Act, which adds consumer-health-data protections on top of federal HIPAA requirements.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Tacoma. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Tacoma
Hipa.ai aggregates every recruiting study in Tacoma from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Tacoma?
There are approximately 183 recruiting clinical trials in Tacoma, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Tacoma pay participants?
Most recruiting trials in Tacoma compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Tacoma?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Tacoma?
The most common conditions under active study in Tacoma include Breast Cancer (8), Multiple Myeloma (8), Crohn's Disease (7), Breast Neoplasms (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Tacoma?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Tacoma on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Tacoma?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Tacoma?
Recruiting research sites in Tacoma include Mary Bridge Children's Hospital and Health Center, Franciscan Research Center-Northwest Medical Plaza, Madigan Army Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Tacoma right now?
The largest active categories in Tacoma are Cancer & tumors (91), Neurology & pain (12), Cardiovascular (12). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.